Stefan Hocht
Overview
Explore the profile of Stefan Hocht including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
255
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Emons G, Steiner E, Vordermark D, Uleer C, Paradies K, Tempfer C, et al.
Geburtshilfe Frauenheilkd
. 2024 Sep;
83(8):963-995.
PMID: 39296646
The S3-guideline on endometrial cancer, first published in April 2018, was reviewed in its entirety between April 2020 and January 2022 and updated. The review was carried out at the...
2.
Emons G, Steiner E, Vordermark D, Uleer C, Paradies K, Tempfer C, et al.
Geburtshilfe Frauenheilkd
. 2023 Aug;
83(8):919-962.
PMID: 37588260
The S3-guideline on endometrial cancer, first published in April 2018, was reviewed in its entirety between April 2020 and January 2022 and updated. The review was carried out at the...
3.
Hocht S, Bohmer D, Wiegel T, Ganswindt U
Urologie
. 2023 Feb;
62(3):299-301.
PMID: 36853507
No abstract available.
4.
Spohn S, Draulans C, Kishan A, Spratt D, Ross A, Maurer T, et al.
Int J Radiat Oncol Biol Phys
. 2023 Jan;
116(3):503-520.
PMID: 36596346
Current risk-stratification systems for prostate cancer (PCa) do not sufficiently reflect the disease heterogeneity. Genomic classifiers (GC) enable improved risk stratification after surgery, but less data exist for patients treated...
5.
Bohmer D, Wiegel T, Hocht S, Ganswindt U
Urologie
. 2022 Oct;
61(12):1387-1389.
PMID: 36260116
No abstract available.
6.
Ghadjar P, Koerber S, Holscher T, Hocht S, Wiegel T
Lancet
. 2022 Sep;
400(10356):883-884.
PMID: 36116475
No abstract available.
7.
Radiotherapy for hormone-sensitive prostate cancer with synchronous low burden of distant metastases
Muller A, Aebersold D, Albrecht C, Bohmer D, Flentje M, Ganswindt U, et al.
Strahlenther Onkol
. 2022 Jun;
198(8):683-689.
PMID: 35704054
Purpose: The DEGRO Expert Commission on Prostate Cancer has revised the indication for radiation therapy of the primary prostate tumor in patients with synchronous distant metastases with low metastatic burden....
8.
Borkowetz A, Blana A, Bohmer D, Cash H, Ehrmann U, Franiel T, et al.
Urol Int
. 2022 Feb;
106(5):431-439.
PMID: 35144260
Background: Focal therapy (FT) is an option to treat localized prostate cancer (PCa) and preserve healthy prostate tissue in order to reduce known side effects from primary whole-gland treatment. The...
9.
Pottgen C, Nestle U, Hocht S, Stuschke M
J Clin Oncol
. 2021 Sep;
39(34):3880-3881.
PMID: 34554877
No abstract available.
10.
Shelan M, Aebersold D, Albrecht C, Bohmer D, Flentje M, Ganswindt U, et al.
Strahlenther Onkol
. 2021 Aug;
197(11):993-1000.
PMID: 34463814
Purpose: Various randomized phase III clinical trials have compared moderately hypofractionated to normofractionated radiotherapy (RT). These modalities showed similar effectiveness without major differences in toxicity. This project was conducted by...